Search results
Results from the WOW.Com Content Network
With the 2001 Thermo Cardiosystems merger, Thoratec acquired the HeartMate Left Ventricular Assist System, an implanted VAD for end-stage heart patients. A landmark three-year study of 129 patients at 22 major medical centers, called REMATCH (Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure) and published in November 2001, found that the HeartMate VE ...
In 2005, Abiomed purchased ventricular assist device company Impella CardioSystems AG of Aachen, Germany, [11] maker of the Impella heart pump, developed by Thorsten Siess, [12] who is now the chief technology officer at Abiomed. [13] [self-published source] After Abiomed acquired Impella the company's focus shifted from heart replacement to ...
[13] [14] [15] In some pulsatile pumps (that use compressed air as an energy source [16]), the volume occupied by blood varies during the pumping cycle. If the pump is contained inside the body then a vent tube to the outside air is required. Continuous-flow VADs are smaller and have proven to be more durable than pulsatile VADs. [17]
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Medical device maker Abiomed Inc said on Tuesday the U.S. Food and Drug Administration granted its left-sided heart pumps emergency use authorization to help patients suffering from COVID-19 ...
For premium support please call: 800-290-4726 more ways to reach us
The HeartAssist5 is a modern version of the DeBakey VAD [10] and as of December 2014 was the only remotely monitored medical device in the world. [8] It was first approved for use in Europe in 2009 under MicroMed Cardiovascular, Inc. [11] The HeartAssist5 is in use in Europe [10] as a destination therapy by patients who are not candidates to receive heart transplants and as a bridge to ...
For premium support please call: 800-290-4726 more ways to reach us